FR-α is highly overexpressed in the vast majority of ovarian cancers but exhibits limited expression in tissues that are responsible for whole body retention of folates (e.g., the placenta, choroid plexus and kidney). This evidence concerns the gene FOLR1 and ovarian cancer.